We are live on ! Find out more
OCDX

Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX

Delisted

OCDX was delisted on the 26th of May, 2022.

Back to rankings

1 hedge funds and large institutions have $1K invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 166 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 170 → 1 (-169)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $4.38B → $1K (-$4.38B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 166

Holders
1
Holders Change
-169
Holders Change %
-99.41%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
166
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CG
Carlyle Group
District of Columbia
-$2.2B
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$364M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$206M
4
BlackRock
BlackRock
New York
-$160M
5
JP Morgan Chase
JP Morgan Chase
New York
-$159M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
51
Citadel Advisors
Florida
– -$4.58M -245,555 Closed
DCM
52
Dupont Capital Management
Delaware
– -$4.27M -228,800 Closed
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$4.23M -226,806 Closed
Bank of America
54
Bank of America
North Carolina
– -$4.18M -224,236 Closed
WMSA
55
Weiss Multi-Strategy Advisers
New York
– -$4.16M -222,998 Closed
SM
56
Senvest Management
New York
– -$4.07M -218,304 Closed
OR
57
Olympiad Research
Connecticut
– -$3.61M -193,253 Closed
Qube Research & Technologies (QRT)
58
Qube Research & Technologies (QRT)
United Kingdom
– -$3.59M -192,462 Closed
Morgan Stanley
59
Morgan Stanley
New York
– -$3.32M -177,661 Closed
PCM
60
Prelude Capital Management
New York
– -$3.28M -175,947 Closed
LP
61
LMR Partners
United Kingdom
– -$3.27M -175,000 Closed
UBS AM
62
UBS AM
Illinois
– -$3.06M -163,776 Closed
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
– -$2.84M -152,197 Closed
GF
64
Gabelli Funds
New York
– -$2.83M -151,503 Closed
Invesco
65
Invesco
Georgia
– -$2.76M -148,009 Closed
American Century Companies
66
American Century Companies
Missouri
– -$2.53M -135,448 Closed
SSA
67
Schonfeld Strategic Advisors
New York
– -$2.48M -133,084 Closed
Wells Fargo
68
Wells Fargo
California
– -$2.42M -129,688 Closed
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
– -$2.35M -125,890 Closed
YCM
70
Yakira Capital Management
Connecticut
– -$2.32M -124,403 Closed
BFM
71
Boothbay Fund Management
New York
– -$2.3M -123,414 Closed
CCM
72
Cinctive Capital Management
New York
– -$2.05M -110,000 Closed
Legal & General Group
73
Legal & General Group
United Kingdom
– -$2.04M -109,440 Closed
GCIA
74
Gabelli & Co Investment Advisers
New York
– -$1.98M -106,097 Closed
CS
75
Credit Suisse
Switzerland
– -$1.91M -102,136 Closed
1 2
3
4 5

OCDX Hedge Fund Activity: Q2 2022 in Review

1 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q2 2022, worth a combined $1K — down 100% from $4.38B a quarter earlier.

Sellers outnumbered buyers: 166 funds closed out of OCDX and 0 opened new positions — a net loss of 166 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Carlyle Group, exiting entirely with an estimated $2.2B sold.

  • 1 institutional investor held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q2 2022, down from 170 in Q1 2022.
  • Funds reported $1K of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q2 2022 and 166 closed out, a net change of -166 holders.
  • The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q2 2022 was Carlyle Group, an estimated $2.2B sold.

Based on aggregated 13F filings for Q2 2022.